InvestorsHub Logo
Followers 20
Posts 1228
Boards Moderated 0
Alias Born 04/13/2013

Re: tradeherpete post# 115235

Saturday, 08/12/2017 7:31:33 PM

Saturday, August 12, 2017 7:31:33 PM

Post# of 458300
Biogen had a major disappointment recently regarding their anti-lingo drug expected to restore mylen. It seems possible they are waiting for the Plus patent before teaming with us. If the patent is broad enough and allows linking A273 with drugs other than aricept, it seems that's what will bring them on board with us, hopefully a sizable initial lump sum and 50/50 partnership for MS. Stranger things have happened.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News